Irisin plays an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, China
Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participa...
Saved in:
Published in | Journal of diabetes investigation Vol. 12; no. 5; pp. 747 - 755 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
John Wiley & Sons, Inc
01.05.2021
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 2040-1116 2040-1124 2040-1124 |
DOI | 10.1111/jdi.13416 |
Cover
Abstract | Aims/Introduction
To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.
Materials and Methods
Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case–control study included 161 participants who developed diabetes mellitus at follow up, and 161 age‐ and sex‐matched controls. The follow‐up study included 86 matched case–control pairs. Fasting serum irisin levels were measured using enzyme‐linked immunosorbent assay.
Results
Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025–1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511–6.218). The extent of decrease in irisin levels during follow‐up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow‐up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112–12.206).
Conclusions
Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals.
This is the first longitudinal study to investigate the potential role of irisin in the outcomes of newly diagnosed prediabetes and whether it can be a predictor of diabetes in prediabetic individuals. We believe that our study makes a significant contribution to the literature, because we found a clear association between serum irisin levels and the outcomes of newly diagnosed prediabetes. |
---|---|
AbstractList | Aims/Introduction
To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.
Materials and Methods
Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case–control study included 161 participants who developed diabetes mellitus at follow up, and 161 age‐ and sex‐matched controls. The follow‐up study included 86 matched case–control pairs. Fasting serum irisin levels were measured using enzyme‐linked immunosorbent assay.
Results
Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025–1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511–6.218). The extent of decrease in irisin levels during follow‐up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow‐up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112–12.206).
Conclusions
Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals.
This is the first longitudinal study to investigate the potential role of irisin in the outcomes of newly diagnosed prediabetes and whether it can be a predictor of diabetes in prediabetic individuals. We believe that our study makes a significant contribution to the literature, because we found a clear association between serum irisin levels and the outcomes of newly diagnosed prediabetes. This is the first longitudinal study to investigate the potential role of irisin in the outcomes of newly diagnosed prediabetes and whether it can be a predictor of diabetes in prediabetic individuals. We believe that our study makes a significant contribution to the literature, because we found a clear association between serum irisin levels and the outcomes of newly diagnosed prediabetes. Aims/IntroductionTo explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.Materials and MethodsData were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case–control study included 161 participants who developed diabetes mellitus at follow up, and 161 age‐ and sex‐matched controls. The follow‐up study included 86 matched case–control pairs. Fasting serum irisin levels were measured using enzyme‐linked immunosorbent assay.ResultsBaseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025–1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511–6.218). The extent of decrease in irisin levels during follow‐up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow‐up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112–12.206).ConclusionsIrisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals. Abstract Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case–control study included 161 participants who developed diabetes mellitus at follow up, and 161 age‐ and sex‐matched controls. The follow‐up study included 86 matched case–control pairs. Fasting serum irisin levels were measured using enzyme‐linked immunosorbent assay. Results Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025–1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511–6.218). The extent of decrease in irisin levels during follow‐up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow‐up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112–12.206). Conclusions Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals. To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.AIMS/INTRODUCTIONTo explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case-control study included 161 participants who developed diabetes mellitus at follow up, and 161 age- and sex-matched controls. The follow-up study included 86 matched case-control pairs. Fasting serum irisin levels were measured using enzyme-linked immunosorbent assay.MATERIALS AND METHODSData were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case-control study included 161 participants who developed diabetes mellitus at follow up, and 161 age- and sex-matched controls. The follow-up study included 86 matched case-control pairs. Fasting serum irisin levels were measured using enzyme-linked immunosorbent assay.Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025-1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511-6.218). The extent of decrease in irisin levels during follow-up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow-up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112-12.206).RESULTSBaseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025-1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511-6.218). The extent of decrease in irisin levels during follow-up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow-up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112-12.206).Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals.CONCLUSIONSIrisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals. To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case-control study included 161 participants who developed diabetes mellitus at follow up, and 161 age- and sex-matched controls. The follow-up study included 86 matched case-control pairs. Fasting serum irisin levels were measured using enzyme-linked immunosorbent assay. Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025-1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511-6.218). The extent of decrease in irisin levels during follow-up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow-up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112-12.206). Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals. |
Author | Liu, Ruoyi Zhang, Miao Xu, Shujing He, Xi Li, Hong Hu, Ying Zhang, Qiao Peng, Nianchun He, Juan Chen, Zhengyi Shi, Lixin |
AuthorAffiliation | 2 Department of Endocrinology and Metabolism Guizhou Provincial People’s Hospital Guiyang China 1 Department of Endocrinology and Metabolism Affiliated Hospital of Guizhou Medical University Guiyang China |
AuthorAffiliation_xml | – name: 1 Department of Endocrinology and Metabolism Affiliated Hospital of Guizhou Medical University Guiyang China – name: 2 Department of Endocrinology and Metabolism Guizhou Provincial People’s Hospital Guiyang China |
Author_xml | – sequence: 1 givenname: Xi orcidid: 0000-0003-4933-1719 surname: He fullname: He, Xi organization: Guizhou Provincial People’s Hospital – sequence: 2 givenname: Qiao surname: Zhang fullname: Zhang, Qiao organization: Affiliated Hospital of Guizhou Medical University – sequence: 3 givenname: Nianchun surname: Peng fullname: Peng, Nianchun organization: Affiliated Hospital of Guizhou Medical University – sequence: 4 givenname: Ying surname: Hu fullname: Hu, Ying organization: Affiliated Hospital of Guizhou Medical University – sequence: 5 givenname: Hong surname: Li fullname: Li, Hong organization: Affiliated Hospital of Guizhou Medical University – sequence: 6 givenname: Zhengyi surname: Chen fullname: Chen, Zhengyi organization: Affiliated Hospital of Guizhou Medical University – sequence: 7 givenname: Ruoyi surname: Liu fullname: Liu, Ruoyi organization: Affiliated Hospital of Guizhou Medical University – sequence: 8 givenname: Shujing surname: Xu fullname: Xu, Shujing organization: Affiliated Hospital of Guizhou Medical University – sequence: 9 givenname: Miao surname: Zhang fullname: Zhang, Miao organization: Affiliated Hospital of Guizhou Medical University – sequence: 10 givenname: Juan surname: He fullname: He, Juan organization: Affiliated Hospital of Guizhou Medical University – sequence: 11 givenname: Lixin surname: Shi fullname: Shi, Lixin email: slx1962@medmail.com.cn organization: Affiliated Hospital of Guizhou Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33000530$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1vEzEQhleoiJbQA38AWeICiLT-Wnv3goQClKBKXOBseb2zqSPHXuxdov33OEmJaCUyF3s8z7wav_bz4swHD0XxkuArkuN63dorwjgRT4oLijmeE0L52XFPxHlxmdIa52BVJYR8VpwzlrOS4YvCLqNN1qPe6Skh7ZHd9CEO2g8oBgcol4Y7QGEcTNhAQqFDHrZuQq3VKx8StKiPkJMGhlzOuG5HN-x3N6OdtF-9R4s76_WL4mmnXYLL-3VW_Pzy-cfi6_z2-81y8fF2bgStxJzVWtQct0J2jTRGclyaumtrISre0VbTBpuOCgKaNAyIFJLR3NGVtK1Z2XA2K5YH3Tboteqj3eg4qaCt2h-EuFI6DtY4UFAbYUA2RteM8xpXwOqKGNk2YEiV9WbFu4PW6Hs9bbVzR0GC1c5-le1Xe_sz_OEA92OzgdaAH6J2DyZ4WPH2Tq3Cb1XhqsZ4J_DmXiCGXyOkQW1sMuCc9hDGpCjnsmKiJCyjrx-h6zBGn31VVHAsqvz68iRVUiwkzZNn6tW_cx8H_vtJMvD2AJgYUorQnTTh-hFr7KAHG3ZXtu5Ux9Y6mP4vrb59Wh46_gCdaOqq |
CitedBy_id | crossref_primary_10_1051_bioconf_202410804002 crossref_primary_10_1016_j_diabres_2023_110642 |
Cites_doi | 10.2337/db17-0002 10.1111/j.1753-0407.2012.00182.x 10.1016/j.metabol.2014.01.005 10.1210/jc.2013-2373 10.1210/jc.2014-2932 10.1056/NEJMoa0908292 10.1111/add.14082 10.1186/1741-7015-11-235 10.3390/cells8101283 10.1016/S2213-8587(14)70144-5 10.1210/jc.2014-1437 10.3389/fphys.2019.00871 10.1038/nrendo.2016.221 10.1111/jdi.12331 10.1155/2019/6737318 10.1016/j.phrs.2018.01.012 10.1111/1753-0407.12256 10.1042/BSR20170213 10.1210/jc.2012-2749 10.1186/s13293-018-0189-3 10.1136/bmj.l4414 10.1016/j.ijcard.2018.05.075 10.1016/j.jdiacomp.2013.03.002 10.1016/j.diabres.2018.03.046 10.1016/j.metabol.2017.05.007 10.1038/s41467-017-01131-0 10.1186/s12933-015-0319-8 10.1001/jama.2013.168118 10.1002/dmrr.3238 10.2337/db13-1106 10.1038/ijo.2015.199 10.1007/s13311-018-0651-2 10.1016/j.metabol.2017.10.011 10.1186/1758-5996-6-133 10.1016/j.amjmed.2014.04.025 10.1042/CS20150009 10.1038/nature10777 10.3945/ajcn.2009.28136 10.1097/MD.0000000000003742 10.1016/S2213-8587(18)30026-3 10.1186/s12933-017-0627-2 10.1002/iub.1511 10.1016/j.metabol.2013.12.007 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S |
ContentType | Journal Article |
Copyright | 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd – notice: 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. – notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7TM 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY DOA |
DOI | 10.1111/jdi.13416 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Open Access Full Text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts Immunology Abstracts ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: BENPR name: ProQuest Central (New) (NC LIVE) url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Role of irisin in prediabetes outcomes |
EISSN | 2040-1124 |
EndPage | 755 |
ExternalDocumentID | oai_doaj_org_article_e9c6ce7bca9344908e3981c7dbec18d9 10.1111/jdi.13416 PMC8089006 33000530 10_1111_jdi_13416 JDI13416 |
Genre | article Journal Article |
GeographicLocations | China United States--US |
GeographicLocations_xml | – name: China – name: United States--US |
GrantInformation_xml | – fundername: National Key R&D Program of China funderid: 2016YFC0901203; 2017YFC1310700; 2017YFC1310701 – fundername: Special Research Project for Public Welfare Industry, National Health and Family Planning Commission of the People’s Republic of China funderid: 201502007 – fundername: Key clinical specialty cultivation project of Guizhou province(2016) funderid: SZD‐2016‐01 – fundername: Fund for Less Developed Regions of the National Natural Science Foundation of China funderid: 81860161 – fundername: National Key R&D Program of China grantid: 2016YFC0901203, – fundername: Fund for Less Developed Regions of the National Natural Science Foundation of China grantid: 81860161 – fundername: National Key R&D Program of China grantid: 2017YFC1310700 – fundername: Special Research Project for Public Welfare Industry, National Health and Family Planning Commission of the People's Republic of China grantid: 201502007 – fundername: Key clinical specialty cultivation project of Guizhou province(2016) grantid: SZD-2016-01 – fundername: National Key R&D Program of China grantid: 2017YFC1310701 – fundername: National Key R&D Program of China grantid: 2016YFC0901203 – fundername: National Key R&D Program of China grantid: 2016YFC0901203; 2017YFC1310700; 2017YFC1310701 – fundername: Key clinical specialty cultivation project of Guizhou province(2016) grantid: SZD‐2016‐01 – fundername: Special Research Project for Public Welfare Industry, National Health and Family Planning Commission of the People’s Republic of China grantid: 201502007 |
GroupedDBID | --- 05W 0R~ 1OC 24P 31~ 4.4 50Y 5DZ 5VS 7X7 8-0 8-1 8FI 8FJ AAHHS AANHP AAZKR ABDBF ABJNI ABUWG ACBWZ ACCFJ ACCMX ACGFO ACPRK ACRPL ACUHS ACXQS ACYXJ ADBBV ADKYN ADNMO ADPDF ADRAZ ADZMN AEEZP AEGXH AENEX AEQDE AFKRA AHMBA AIAGR AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS ASPBG AVUZU AVWKF AZFZN BAWUL BCNDV BDRZF BENPR BPHCQ BVXVI CAG CCPQU COF DIK EBD EBS EJD FYUFA GODZA GROUPED_DOAJ GX1 HMCUK HYE HZ~ KQ8 LH4 LW6 M48 MY. O9- OK1 OVD PIMPY PQQKQ PROAC RPM RX1 SUPJJ TEORI UKHRP WIN AAMMB AAYXX AEFGJ AGQPQ AGXDD AIDQK AIDYY CITATION PHGZM PHGZT PUEGO CGR CUY CVF ECM EIF NPM 3V. 7T5 7TM 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c6286-39a6940d67fb7cc7405c9fd96684f2da2b0cf261ea1b3e176732a69f52d935b43 |
IEDL.DBID | DOA |
ISSN | 2040-1116 2040-1124 |
IngestDate | Wed Aug 27 01:00:08 EDT 2025 Wed Oct 01 15:54:47 EDT 2025 Tue Sep 30 16:59:35 EDT 2025 Fri Sep 05 09:11:37 EDT 2025 Fri Jul 25 07:40:29 EDT 2025 Sun Sep 07 03:43:09 EDT 2025 Thu Apr 03 07:05:46 EDT 2025 Thu Apr 24 23:09:10 EDT 2025 Wed Oct 01 03:30:53 EDT 2025 Wed Jan 22 16:30:44 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Prediabetes Irisin Diabetes |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. cc-by-nc-nd |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c6286-39a6940d67fb7cc7405c9fd96684f2da2b0cf261ea1b3e176732a69f52d935b43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-4933-1719 |
OpenAccessLink | https://doaj.org/article/e9c6ce7bca9344908e3981c7dbec18d9 |
PMID | 33000530 |
PQID | 2520672134 |
PQPubID | 1006415 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e9c6ce7bca9344908e3981c7dbec18d9 unpaywall_primary_10_1111_jdi_13416 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8089006 proquest_miscellaneous_2447836513 proquest_journals_2640682047 proquest_journals_2520672134 pubmed_primary_33000530 crossref_primary_10_1111_jdi_13416 crossref_citationtrail_10_1111_jdi_13416 wiley_primary_10_1111_jdi_13416_JDI13416 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2021 |
PublicationDateYYYYMMDD | 2021-05-01 |
PublicationDate_xml | – month: 05 year: 2021 text: May 2021 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Richmond – name: Hoboken |
PublicationTitle | Journal of diabetes investigation |
PublicationTitleAlternate | J Diabetes Investig |
PublicationYear | 2021 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
References | 2019; 8 2012; 481 2018; 141 2019; 2019 2017; 8 2015; 6 2013; 27 2018; 129 2019; 10 2017; 66 2015; 100 2018; 267 2019; 366 2016; 95 2006 2010; 362 2020; 36 2015; 129 2014; 63 2016; 15 2017; 73 1998; 15 2018; 6 2018; 9 2014; 127 2014; 2 2013; 11 2017; 37 2013; 98 2017; 16 2018; 113 2017; 13 2013; 310 2016; 40 2010; 91 2012; 4 2014; 6 2016; 8 2014; 99 2018; 15 2016; 68 2018; 79 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_14_1 World Health Organization (e_1_2_7_24_1) 2006 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 |
References_xml | – volume: 79 start-page: 24 year: 2018 end-page: 32 article-title: Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: a cross sectional and a prospective case‐control study nested in the Normative Aging Study publication-title: Metabolism – volume: 9 start-page: 28 year: 2018 article-title: Sex differences in body composition and association with cardiometabolic risk publication-title: Biol Sex Differ – volume: 10 start-page: 871 year: 2019 article-title: Circulating irisin and myostatin as markers of muscle strength and physical condition in elderly subjects publication-title: Front Physiol – volume: 6 start-page: 571 year: 2015 end-page: 576 article-title: Irisin levels are associated with urotensin II levels in diabetic patients publication-title: J Diabetes Investig – volume: 100 start-page: 1289 year: 2015 end-page: 1299 article-title: Serum irisin levels are regulated by acute strenuous exercise publication-title: J Clin Endocrinol Metab – volume: 366 start-page: l4414 year: 2019 article-title: Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow‐up of Whitehall II cohort study publication-title: BMJ – volume: 129 start-page: 839 year: 2015 end-page: 850 article-title: Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes publication-title: Clin Sci (Lond) – volume: 36 year: 2020 article-title: Irisin increases the expression of anorexigenic and neurotrophic genes in mouse brain publication-title: Diabetes Metab Res Rev – volume: 91 start-page: 7 year: 2010 end-page: 15 article-title: Racial differences in abdominal depot‐specific adiposity in white and African American adults publication-title: Am J Clin Nutr – volume: 11 start-page: 235 year: 2013 article-title: Irisin and exercise training in humans ‐ results from a randomized controlled training trial publication-title: BMC Med – volume: 40 start-page: 443 year: 2016 end-page: 451 article-title: Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway publication-title: Int J Obes (Lond) – volume: 141 start-page: 10 year: 2018 end-page: 17 article-title: High irisin levels are associated with better glycemic control and bone health in children with type 1 diabetes publication-title: Diabetes Res Clin Pract – volume: 13 start-page: 324 year: 2017 end-page: 337 article-title: Physiology and role of irisin in glucose homeostasis publication-title: Nat Rev Endocrinol – volume: 8 start-page: 1283 year: 2019 article-title: Increased expression of meteorin‐like hormone in type 2 diabetes and obesity and its association with irisin publication-title: Cells – volume: 310 start-page: 948 year: 2013 end-page: 959 article-title: Prevalence and control of diabetes in Chinese adults publication-title: JAMA – volume: 63 start-page: 514 year: 2014 end-page: 525 article-title: Irisin stimulates browning of white adipocytes through mitogen‐activated protein kinase p38 MAP kinase and ERK MAP kinase signaling publication-title: Diabetes – volume: 8 start-page: 56 year: 2016 end-page: 62 article-title: Lower irisin level in patients with type 2 diabetes mellitus: a case‐control study and meta‐analysis publication-title: J Diabetes – volume: 15 start-page: 9 year: 2016 article-title: The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype publication-title: Cardiovasc Diabetol – volume: 63 start-page: 574 year: 2014 end-page: 583 article-title: Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels publication-title: Metabolism – volume: 98 start-page: 4899 year: 2013 end-page: 4907 article-title: Circulating irisin in relation to insulin resistance and the metabolic syndrome publication-title: J Clin Endocrinol Metab – volume: 95 year: 2016 article-title: High serum irisin level as an independent predictor of diabetes mellitus: a longitudinal population‐based study publication-title: Medicine (Baltimore) – volume: 113 start-page: 719 year: 2018 end-page: 728 article-title: Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002–14: emerging disparities in vulnerable populations publication-title: Addiction – volume: 6 start-page: 133 year: 2014 article-title: Circulating levels of irisin in middle‐aged first‐degree relatives of type 2 diabetes mellitus — correlation with pancreatic β‐cell function publication-title: Diabetol Metab Syndr – volume: 98 start-page: E769 year: 2013 end-page: E778 article-title: Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance publication-title: J Clin Endocrinol Metab – volume: 37 start-page: BSR20170213 year: 2017 article-title: The relationship between circulating irisin levels and tissues AGE accumulation in type 2 diabetes patients publication-title: Biosci Rep – volume: 99 start-page: E2154 year: 2014 end-page: E2161 article-title: Exercise‐induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation publication-title: J Clin Endocrinol Metab – volume: 2019 start-page: 6737318 year: 2019 article-title: Association between irisin, hs‐CRP, and metabolic status in children and adolescents with type 2 diabetes mellitus publication-title: Mediators Inflamm – volume: 362 start-page: 1090 year: 2010 end-page: 1101 article-title: Prevalence of diabetes among men and women in China publication-title: N Engl J Med – volume: 66 start-page: 2849 year: 2017 end-page: 2856 article-title: The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β‐cell survival and insulin secretion publication-title: Diabetes – volume: 4 start-page: 172 year: 2012 end-page: 173 article-title: Reaction Study Group. Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study publication-title: J Diabetes – volume: 8 start-page: 1104 year: 2017 article-title: Irisin is a pro‐myogenic factor that induces skeletal muscle hypertrophy and rescues denervation‐induced atrophy publication-title: Nat Commun – volume: 129 start-page: 44 year: 2018 end-page: 55 article-title: A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: an introductory review publication-title: Pharmacol Res – volume: 63 start-page: 520 year: 2014 end-page: 531 article-title: Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight‐lowering program in obese patients publication-title: Metabolism – volume: 15 start-page: 539 year: 1998 end-page: 553 article-title: Diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation publication-title: Diabet Med – volume: 2 start-page: 969 year: 2014 end-page: 979 article-title: Diabetes in China: a societal solution for a personal challenge publication-title: Lancet Diabetes Endocrinol – volume: 481 start-page: 463 year: 2012 end-page: 468 article-title: A PGC1‐α‐dependent myokine that drives brown‐fat‐like development of white fat and thermogenesis publication-title: Nature – year: 2006 – volume: 15 start-page: 1158 year: 2018 end-page: 1167 article-title: Decreased concentration of irisin is associated with poor functional outcome in ischemic stroke publication-title: Neurotherapeutics – volume: 27 start-page: 365 year: 2013 end-page: 369 article-title: Lower circulating irisin is associated with type 2 diabetes mellitus publication-title: J Diabetes Complications – volume: 73 start-page: 100 year: 2017 end-page: 108 article-title: Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents publication-title: Metabolism – volume: 68 start-page: 544 year: 2016 end-page: 556 article-title: Circulating serum irisin levels in obesity and type 2 diabetes mellitus publication-title: IUBMB Life – volume: 267 start-page: 177 year: 2018 end-page: 182 article-title: Relationship of serum irisin levels to prevalence and progression of coronary artery calcification: a prospective, population‐based study publication-title: Int J Cardiol – volume: 127 start-page: 888 year: 2014 end-page: 890 article-title: Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity publication-title: Am J Med – volume: 16 start-page: 147 year: 2017 article-title: Plasma irisin is elevated in type 2 diabetes and is associated with increased E‐selectin levels publication-title: Cardiovasc Diabetol – volume: 6 start-page: 647 year: 2018 end-page: 658 article-title: The physiology of endocrine systems with ageing publication-title: Lancet Diabetes Endocrinol – ident: e_1_2_7_28_1 doi: 10.2337/db17-0002 – ident: e_1_2_7_22_1 doi: 10.1111/j.1753-0407.2012.00182.x – ident: e_1_2_7_41_1 doi: 10.1016/j.metabol.2014.01.005 – ident: e_1_2_7_16_1 doi: 10.1210/jc.2013-2373 – volume-title: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation year: 2006 ident: e_1_2_7_24_1 – ident: e_1_2_7_34_1 doi: 10.1210/jc.2014-2932 – ident: e_1_2_7_26_1 doi: 10.1056/NEJMoa0908292 – ident: e_1_2_7_25_1 doi: 10.1111/add.14082 – ident: e_1_2_7_33_1 doi: 10.1186/1741-7015-11-235 – ident: e_1_2_7_15_1 doi: 10.3390/cells8101283 – ident: e_1_2_7_2_1 doi: 10.1016/S2213-8587(14)70144-5 – ident: e_1_2_7_6_1 doi: 10.1210/jc.2014-1437 – ident: e_1_2_7_40_1 doi: 10.3389/fphys.2019.00871 – ident: e_1_2_7_21_1 doi: 10.1038/nrendo.2016.221 – ident: e_1_2_7_46_1 doi: 10.1111/jdi.12331 – ident: e_1_2_7_12_1 doi: 10.1155/2019/6737318 – ident: e_1_2_7_32_1 doi: 10.1016/j.phrs.2018.01.012 – ident: e_1_2_7_11_1 doi: 10.1111/1753-0407.12256 – ident: e_1_2_7_45_1 doi: 10.1042/BSR20170213 – ident: e_1_2_7_10_1 doi: 10.1210/jc.2012-2749 – ident: e_1_2_7_31_1 doi: 10.1186/s13293-018-0189-3 – ident: e_1_2_7_27_1 doi: 10.1136/bmj.l4414 – ident: e_1_2_7_36_1 doi: 10.1016/j.ijcard.2018.05.075 – ident: e_1_2_7_44_1 doi: 10.1016/j.jdiacomp.2013.03.002 – ident: e_1_2_7_14_1 doi: 10.1016/j.diabres.2018.03.046 – ident: e_1_2_7_17_1 doi: 10.1016/j.metabol.2017.05.007 – ident: e_1_2_7_39_1 doi: 10.1038/s41467-017-01131-0 – ident: e_1_2_7_9_1 doi: 10.1186/s12933-015-0319-8 – ident: e_1_2_7_3_1 doi: 10.1001/jama.2013.168118 – ident: e_1_2_7_29_1 doi: 10.1002/dmrr.3238 – ident: e_1_2_7_5_1 doi: 10.2337/db13-1106 – ident: e_1_2_7_8_1 doi: 10.1038/ijo.2015.199 – ident: e_1_2_7_35_1 doi: 10.1007/s13311-018-0651-2 – ident: e_1_2_7_20_1 doi: 10.1016/j.metabol.2017.10.011 – ident: e_1_2_7_42_1 doi: 10.1186/1758-5996-6-133 – ident: e_1_2_7_37_1 doi: 10.1016/j.amjmed.2014.04.025 – ident: e_1_2_7_7_1 doi: 10.1042/CS20150009 – ident: e_1_2_7_4_1 doi: 10.1038/nature10777 – ident: e_1_2_7_30_1 doi: 10.3945/ajcn.2009.28136 – ident: e_1_2_7_19_1 doi: 10.1097/MD.0000000000003742 – ident: e_1_2_7_38_1 doi: 10.1016/S2213-8587(18)30026-3 – ident: e_1_2_7_13_1 doi: 10.1186/s12933-017-0627-2 – ident: e_1_2_7_43_1 doi: 10.1002/iub.1511 – ident: e_1_2_7_18_1 doi: 10.1016/j.metabol.2013.12.007 – ident: e_1_2_7_23_1 doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S |
SSID | ssj0000388667 |
Score | 2.2355964 |
Snippet | Aims/Introduction
To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.
Materials and Methods
Data were obtained from the... To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Data were obtained from the Guiyang subcenter of the Risk Evaluation of... Aims/IntroductionTo explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.Materials and MethodsData were obtained from the... To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.AIMS/INTRODUCTIONTo explore the potential role of irisin in the outcomes... This is the first longitudinal study to investigate the potential role of irisin in the outcomes of newly diagnosed prediabetes and whether it can be a... Abstract Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained... |
SourceID | doaj unpaywall pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 747 |
SubjectTerms | Aged Alcohol Autoimmune diseases Blood pressure Body mass index Cardiovascular disease Case-Control Studies China - epidemiology Cholesterol Creatinine Diabetes Diabetes mellitus Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - epidemiology Enzymes Epidemiology Fasting - blood Female Fibronectins - blood Follow-Up Studies Glucose Hemoglobin High density lipoprotein Humans Hypertension Insulin resistance Irisin Laboratories Longitudinal Studies Male Middle Aged Odds Ratio Original Plasma Prediabetes Prediabetic State - blood Prediabetic State - diagnosis Proteins Regression analysis Risk Assessment Risk Factors Smoking Variance analysis |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSMAF8SZQkHkceiCQ-BmfEK9SKpUTlfYWOX6USMEJuxuh_ffYXm9QxNJblJlIsT1jf_aMvwHglaVUCkVlbnFhciKRzoUhLOcFshUikpB4Q-7sGzs5J6cLukgHbquUVrmbE-NErXsVzsjfIhqIxgP_2LvhVx6qRoXoaiqhcRVcKz1UCVbNF3w6YwlMJywWkUUhcc67NUvkQjGZR7dvAp0Zmy1Jkbl_H9z8N2vyxugGufktu26ObOPSdHwb3EqYEr7fGsEdcMW4u-D6WYqa3wNtKCPfOjh0crOC0sH2Z0Tdbg1DciH0Ig8DYT-ufVeYFewt9GC720C9zcMzGg5LszulDeqRtSM-fRnbjXQXr2EsxH0fnB9__v7xJE8lFnIV7qTmWEgmSKEZtw1Xinv4poTVfg9UEYu0RE2hrN9kGVk22JSccYz8F5YiLTBtCH4ADlzvzCMAtTSS8qaxyGrSWFlhy3VphaBaNsjgDBzterlWiX88lMHo6mkfots6DkgGXkyqw5Z0Y5_ShzBUk0LgyY4v-uVFndyuNkIxZXijpMAkxDgNFlWpuPamW1ZaZOBwN9B1ct5V_dfU9ouZB0EeOBGegeeT2HtlCLVIZ_rR6xASrsfQ0jf74dZsph_FON6ALjLAZwY1a8lc4tofkfm7Kirhp8kMvJxM77IOOopG-X-N-vTT1_jw-PJueAJuopDKE_M8D8HBejmapx6LrZtn0eH-AAmaMnI priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwFLZKkYALYidQkFkOPZAq8RofEGIrpdJwYqTeIq8lUkiGmYkg_x7bk0SKGDhxi-JnKX7-bH-On78HwEtHqRSaytThzKZEIpMKS1jKM-QKRCQh8Ybc4gs7W5LzC3pxAMYcm4MDN3u3diGf1HJdn_z60b_xA_71FJVjqpOgS8augKt-QUIB3IuB5ccJGRcFi7lkUYif81XYoDE0qz1bmaKA_z7W-Wfw5PWuWcn-p6zrOcGNK9TpLXBzoJbw7Q4Lt8GBbe6Aa4vh8PwuqEI2-aqBq1r2GygbWH2P7W62MMQYQl_k2SBsu61Hod3A1kHPueseml04njVwtbbjz9pgHsU74tOnruplc_kKxnzc98Dy9OPX92fpkGkh1eFqaoqFZIJkhnGnuNbcszgtnPFboYI4ZCRSmXZ-r2VlrrDNOeMY-RqOIiMwVQTfB4dN29iHABppJeVKOeQMUU4W2HGTOyGokQpZnIDj0culHmTIQzaMupy2I6YqY4ck4Plkutppb-wzehe6ajIIctnxRbu-LIfRV1qhmbZcaSkwCUedFosi19x4BOeFEQk4Gju6HCFYIhqk7YPi3f5i5rmQ50-EJ-DZVOwHZzhxkY1tO29DSLglQ3Pf7Ac72EwfinG8CJ0lgM8ANWvJvKSpvkUB8CIrhJ8tE_Bigt6_HHQcQfl3i_L8w-f48Oh_-PIxuIFC3E8MCj0Ch9t1Z5944rZVT-Ow_A1A5UG_ priority: 102 providerName: Scholars Portal – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgK0EvvB-Bgszj0ANZEtuJ42N5lFKpFQdWKqfgZ4kakmg3EVp-PbaTDQosCImbFY-T2JlxPtsz3wDw3CQJZzLhocGRDglHKmSapCGNkMkQ4YT4CLmT0_RoQY7PkrMhz6mLhen5IcYNN2cZfr52Bt4o08_zL0d_HFXMHSNZehnspO6EaQZ2FqcfDj65lHLOV84KpT_LiAzcQpO2kz-SJ-7fhjZ_d5q82lUNX3_jZTkFtv7PdHgdfN70qXdIuZh3rZjL77_QPf5Hp2-AawNqhQe9mt0El3R1C1w5Gc7lb4PCJaovKtiUfL2CvILFV4_rqxY690VoqyzQhHXX2gfqFawNtHC-XEPVe_ppBZul3uwDO3HPC-JL77pizavzF9Cn-r4DFodvP74-CockDqF0Ua8hZjxlJFIpNYJKSS1AlMwou8rKiEGKIxFJY5dxmscC65imFCPbwiRIMZwIgu-CWVVX-j6AimueUCEMMooIwzNsqIoNY4niAmkcgP3Nh8zlwHDuEm2U-bjSUUXuhy4AT0fRpqf12Cb0ymnDKOCYuP2FenmeD4adayZTqamQnGHiTlE1ZlksqbLGEWeKBWBvo0v5MD2scpQ41nxHpre9OrUwy0IzQgPwZKy2du8Oc3il687KEOICcJLYdvter5nji2LsY6yjANCJzk56Mq2pii-eWzyLMmYn4gA8G7X7bwO075X1zxL58Zv3vvDgn274EOwi5zPkHUr3wKxddvqRBX2teDwY9g9g5FYv priority: 102 providerName: Unpaywall – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jb9QwFLZKkaAXxN5AQWY59EBQ4jUWJ7ZSKhVxoFJvkdcSaXBGMxOh-ffYziIiBsTNip-l2H7P_my_9z0AXjpKpdBU5g4XNicSmVxYwnJeIFchIglJEXLnX9jpBTm7pJd74M0YC9PzQ0wXbtEy0nodDVyq9e9GbprXkY2MXQPXy7jrR1pn8nW6YIk0JyxlkEXRay40YgOzUPLkGVvP9qNE278La_7pMnmz80u5_SkXizmsTfvSyW1wawCU8G2vAXfAnvV3wY3z4cn8HmhiDvnGw-VCbtdQetj8SJDbb2D0LIShKmBA2HabMAB2DVsHA9JebKHpnfCsgcuVHa9oo3ii7EilT12zlf7qFUxZuO-Di5OP396f5kN-hVzHgNQcC8kEKQzjTnGtecBuWjgTDkAVcchIpArtwgnLylJhW3LGMQotHEVGYKoIfgD2fevtIYBGWkm5Ug45Q5STFXbclE4IaqRCFmfgeBzlWg_k4zEHxqKeDiGmqdOEZOD5JLrsGTd2Cb2LUzUJRJLs9KFdXdWDzdVWaKYtV1oKTOIDp8WiKjU3QW_LyogMHI0TXQ-Wu64RjYT2kedudzULCCigJsIz8GyqDiYZ31mkt20XZAiJsTG0DN1-2KvN9KMYp_DnIgN8plCznsxrfPM90X5XRSXCGpmBF5Pq_WuAjpNS_l2iPvvwORUe_b_oY3CAok9Pcvg8AvubVWefBFC2UU-T8f0C04Yybg priority: 102 providerName: Wiley-Blackwell |
Title | Irisin plays an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, China |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdi.13416 https://www.ncbi.nlm.nih.gov/pubmed/33000530 https://www.proquest.com/docview/2520672134 https://www.proquest.com/docview/2640682047 https://www.proquest.com/docview/2447836513 https://pubmed.ncbi.nlm.nih.gov/PMC8089006 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdi.13416 https://doaj.org/article/e9c6ce7bca9344908e3981c7dbec18d9 |
UnpaywallVersion | publishedVersion |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: KQ8 dateStart: 20140101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: KQ8 dateStart: 20100101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: DOA dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCO Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: ABDBF dateStart: 20120401 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: RPM dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: 7X7 dateStart: 20140101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central (New) (NC LIVE) customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: BENPR dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2040-1124 dateEnd: 20250630 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: M48 dateStart: 20100501 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVWIB databaseName: KBPluse Wiley Online Library: Open Access customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: AVUZU dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559 providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2040-1124 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000388667 issn: 2040-1116 databaseCode: 24P dateStart: 20100101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZgkYAL4k1gqczjsAcCie3E8XEXdllWalUhKpVT5CdECmm1bYT67xk7abQVBS5cLMueKLE9tj_HM98g9NplmRQ6k7GjiY2ZJCYWluUxT4grCJOMBQ-58SQ_n7GLeTa_EurL24R19MBdx72zQufacqWloMzfUlkqilRzAy9PCxNc92Abu3KYCmswLYo8hI8l3mQOJnTe0woFMx5TvfVEZvnOZhQ4-_cBzd_tJW-1zVJufsq63sW0YVM6u4vu9GgSH3etuIeu2eY-ujnu78sfoMoHkK8avKzlZoVlg6sfAW83a-zNCjFUAQDEi3YNimdXeOEwwOx6g01ngWcNXl7a7f9ZLx74OkLuY1ttZPPtDQ4huB-i2dnpl_fncR9cIdbeGzWmQuaCJSbnTnGtOQA3LZyB00_BHDGSqEQ7OF5ZmSpqU55zSuAJlxEjaKYYfYQOmkVjnyBspJUZV8oRZ5hysqCOm9QJkRmpiKUROtr2cql75nEfAKMuhxOIqcowIBF6OYguO7qNfUInfqgGAc-QHQpAb8peb8p_6U2EDrcDXfbTdlWSzLPZe5K7_dU5wB-ATIxH6MVQDfPRX7LIxi5akGHMO8ZkKTT7cac2w4dSGnyfkwjxHYXaacluTVN9D5zfRVIIWCAj9GpQvb910FFQyj9LlBcfPoXM0__Rl8_QbeJNfYId6CE6WF-29jlgtbUaoeuETSHlcz5CN05OJ9PPozBVIR2zAspmk-nx119X5kHt |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSgXxJtAAfOSeiCQ2E4cHxACStltuz210t6C40eJtCTL7kbV_il-Ix5vErRi6a23KJ5E8Xg8-WzPfIPQa5skUqhEhpZGJmSS6FAYloY8IjYjTDLmM-RGJ-ngjB2Ok_EW-t3lwkBYZecTvaPWtYI98vckAaJx4B_7OP0VQtUoOF3tSmiszOLILC_ckm3-YbjvxvcNIQdfT78MwraqQKggDTOkQqaCRTrltuBKcYdYlLDawf6MWaIlKSJl3brCyLigJuYpp8Q9YROiBU0KRt17r6HrjEYMuPr5mPd7OsCskvqitQQC9ZwbSVsyIx88pMt3QJ-Wrv0CfaWATfD23yjNnaaayuWFnEzWkbT_FR7cRrdaDIs_rYzuDtoy1V10Y9Se0t9DJZStLys8ncjlHMsKlz89yq8WGIIZsWtysBPXzcKp3sxxbbED95Ml1qu4P6PxdGa6XWEQ9ywh_upbUy5ldf4W-8Lf99HZlSj_Adqu6so8QlhLIxNeFJZYzQorM2q5jq0QiZYFMTRAe52Wc9XynUPZjUner3t0mfsBCdDLXnS6IvnYJPQZhqoXAF5uf6OeneftNM-NUKkyvFBSUAZnqoaKLFZcu6kSZ1oEaLcb6Lx1FvP8r2lvbk4d6HJAjfEAveibnReAox1ZmbpxMoxBOk4Su24_XJlN_6GU-ozrKEB8zaDWerLeUpU_PNN4FmXCueUAvepN7zIF7Xmj_L9Efrg_9BePL1fDc7QzOB0d58fDk6Mn6CaBMCIfY7qLthezxjx1OHBRPPOTD6PvVz3b_wDOmm5c |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkQoXxJtAAfOSeiA0sZ04PiAELEu3pRUHKu0tOH6USCFZ9qFq_xq_Do83CVqx9NZbtJ6NEs8jY_ubbxB6aZNECpXI0NLIhEwSHQrD0pBHxGaEScZ8hdzxSXpwyg7HyXgL_e5qYQBW2cVEH6h1o2CPfJ8kQDQO_GP7toVFfB0M301-hdBBCk5au3YaKxM5Mstzt3ybvR0NnK5fETL89O3jQdh2GAgVlGSGVMhUsEin3BZcKe6yFyWsdkuAjFmiJSkiZd0aw8i4oCbmKafE_cMmRAuaFIy6-15BVzllFOBkfMz7_R1gWUl9A1sCoD0XUtKW2MgDiXT5BqjU0rXPoe8asCnV_RexeW1RT-TyXFbVelbtP4vDm-hGm8_i9ysDvIW2TH0b7Ry3J_Z3UAkt7MsaTyq5nGFZ4_Knz_jrOQZgI3ZDLgXFzWLu1GBmuLHYJfrVEusVBtBoPJmabocYxD1jiL_6vCiXsj57jX0T8Lvo9FIm_x7arpvaPEBYSyMTXhSWWM0KKzNquY6tEImWBTE0QHvdLOeq5T6HFhxV3q-BdJl7hQToeS86WRF-bBL6AKrqBYCj2__QTM_y1uVzI1SqDC-UFJTB-aqhIosV185t4kyLAO12is7bwDHL_5r55uHUJWAuaWM8QM_6YRcR4JhH1qZZOBnGoDQnid1r31-ZTf-glPrq6yhAfM2g1t5kfaQuf3jW8SzKhAvRAXrRm95FE7TnjfL_EvnhYOQvHl48DU_RjvPz_Mvo5OgRuk4AUeThprtoez5dmMcuJZwXT7zvYfT9sp39DxZccpc |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgK0EvvB-Bgszj0ANZEtuJ42N5lFKpFQdWKqfgZ4kakmg3EVp-PbaTDQosCImbFY-T2JlxPtsz3wDw3CQJZzLhocGRDglHKmSapCGNkMkQ4YT4CLmT0_RoQY7PkrMhz6mLhen5IcYNN2cZfr52Bt4o08_zL0d_HFXMHSNZehnspO6EaQZ2FqcfDj65lHLOV84KpT_LiAzcQpO2kz-SJ-7fhjZ_d5q82lUNX3_jZTkFtv7PdHgdfN70qXdIuZh3rZjL77_QPf5Hp2-AawNqhQe9mt0El3R1C1w5Gc7lb4PCJaovKtiUfL2CvILFV4_rqxY690VoqyzQhHXX2gfqFawNtHC-XEPVe_ppBZul3uwDO3HPC-JL77pizavzF9Cn-r4DFodvP74-CockDqF0Ua8hZjxlJFIpNYJKSS1AlMwou8rKiEGKIxFJY5dxmscC65imFCPbwiRIMZwIgu-CWVVX-j6AimueUCEMMooIwzNsqIoNY4niAmkcgP3Nh8zlwHDuEm2U-bjSUUXuhy4AT0fRpqf12Cb0ymnDKOCYuP2FenmeD4adayZTqamQnGHiTlE1ZlksqbLGEWeKBWBvo0v5MD2scpQ41nxHpre9OrUwy0IzQgPwZKy2du8Oc3il687KEOICcJLYdvter5nji2LsY6yjANCJzk56Mq2pii-eWzyLMmYn4gA8G7X7bwO075X1zxL58Zv3vvDgn274EOwi5zPkHUr3wKxddvqRBX2teDwY9g9g5FYv |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Irisin+plays+an+important+role+in+the+outcomes+of+newly+diagnosed+prediabetes+in+adults+in+Guiyang%2C+China&rft.jtitle=Journal+of+diabetes+investigation&rft.au=Xi+He&rft.au=Qiao+Zhang&rft.au=Nianchun+Peng&rft.au=Ying+Hu&rft.date=2021-05-01&rft.pub=Wiley&rft.issn=2040-1116&rft.eissn=2040-1124&rft.volume=12&rft.issue=5&rft.spage=747&rft.epage=755&rft_id=info:doi/10.1111%2Fjdi.13416&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e9c6ce7bca9344908e3981c7dbec18d9 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2040-1116&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2040-1116&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2040-1116&client=summon |